Chapter 11 : : Adaptation and Survival in the Urogenital Tract

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in

: Adaptation and Survival in the Urogenital Tract, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818104/9781555811594_Chap11-1.gif /docserver/preview/fulltext/10.1128/9781555818104/9781555811594_Chap11-2.gif


Uncomplicated gonorrhea is most commonly an acute urogenital infection involving the urethra in men and the endocervix in women of reproductive age. Upon entering the urogenital tract, adheres to columnar epithelial cells, a step that presumably enables the gonococcus to withstand the flushing force of urine and the constant shedding of cervical mucus. Transcriptional regulation of genes in response to environmental stimuli in the mucus layer may coordinate adaptation of this pathogen to nutritionally different microenvironments and to physiological stress induced by nonspecific host defenses. The major pilin subunit, PilE, is encoded by one or two expression loci () on the chromosome. This chapter focuses on the survival mechanisms utilized by the gonococcus specifically in the context of the urogenital mucosa. The isolation of a gonococcal mutant by Thomas and Sparling facilitated the identification of numerous -dependent iron-induced (Fip) and iron-repressed (Frp) proteins by two-dimensional electrophoresis; from this work one might predict the existence of gonococcal virulence genes that are regulated by iron but not involved in iron uptake. Insights from these studies have fostered theories regarding the functions of these molecules and the role of variable gene expression in gonococcal adaptation and transmission. The development of animal models for studying specific aspects of gonococcal infection in a female background should also be pursued, incorporating transgenic mice when possible to better mimic human infection.

Citation: Jerse A. 2000. : Adaptation and Survival in the Urogenital Tract, p 201-227. In Nataro J, Blaser M, Cunningham-Rundles S (ed), Persistent Bacterial Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818104.ch11

Key Concept Ranking

Tumor Necrosis Factor alpha
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of FIGURE 1

Colonization of the urogenital mucosa by . Initial bacterial adherence to the urethral or cervical mucosa is mediated by gonococcal pili. Gonococcal pili are composed of the antigenically variable pilin subunit PilE and several pilin-associated proteins, including the tip-associated adhesin PilC (reviewed in reference ). Adherence to the CD46 receptor via the tip-associated PilC adhesin is depicted, although it has not yet been reported if the PilC adhesin binds to this receptor. Adherence capabilities are also inherent in the PilE subunit ( ). Binding between Opa proteins and members of the CD66 family expressed on epithelial cells can occur w i t h or without uptake, depending on the particular Opa protein and CD66 receptor involved. Opamediated adherence to CD66 receptors on neutrophils can result in nonopsonic uptake. Opa proteins differ in the capacity to bind to various members of the CD66 family, thereby conferring tropism for different cells. Some Opa proteins utilize heparin sulfate molecules to mediate invasion of epithelial cells; entry via Opa protein-heparin sulfate-vitronectin interactions has also been reported (reviewed in reference ). Expression of gonococcal pili, Opa proteins, and LOS undergoes phase and antigenic variation. This characteristic is represented by gonococci having different combinations of these molecules and expressing LOSs of different lengths. Binding of a gonococcal LOS variant expressing a terminal lacto-N-neotetraose molecule to the asialoglycoprotein receptor (ASPG-R) is also shown ( ). Sialylation of the terminal galactose in this tetrasaccharide, an event that is catalyzed by the gonococcal sialyltransferase (STase) ( ), blocks gonococcal epithelial cell invasion by an unknown mechanism ( ). Intracellular replication and survival are enhanced by the cleavage of LAMP1, a late endosomal maturation protein, by IgAl protease ( ). A nonpiliated gonococcus is shown traversing the cell, based on reports that piliation impedes traversal ( ) or is lost ( ) during this process. Passage of the gonococcus to the subepithelium may ultimately provide access to the bloodstream, leading to DGI.

Citation: Jerse A. 2000. : Adaptation and Survival in the Urogenital Tract, p 201-227. In Nataro J, Blaser M, Cunningham-Rundles S (ed), Persistent Bacterial Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818104.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2

Cyclical fluctuation of host factors that may challenge the survival of during infection of the female genital tract. Shading is used to illustrate relative differences in mucus viscosity ( ), commensal flora ( ), and local concentrations of reproductive hormones ( ), lactoferrin ( ), and secretory IgA ( ). Light shading is used to represent a pH of < 7 ; moderate shading represents neutral pH. The pH of vaginal mucus is based on a reported pH value of 4.6 (range, 3.3 to 7.4) on days 9 and 10 and 4.4 (range, 3.6 to 6.0) on days 22 to 24 of the cycle. Cervical mucus pH is based on a reported average of 6.8 (range, 5.5 to 8.0) on days 9 and 10 and 6.1 (range, 5.1 to 8.4) on days 22 and 24 ( ). In a study of 50 women with cervical gonorrhea, the cervical mucus pH ranged from 6.8 to 7.6 during the proliferative stage (days 6 to 12), 5.2 to 6.6 during the secretory phase (days 20 to 25), and 4.8 to 7.4 just prior to and during menses (days 26 to 5) ( ).

Citation: Jerse A. 2000. : Adaptation and Survival in the Urogenital Tract, p 201-227. In Nataro J, Blaser M, Cunningham-Rundles S (ed), Persistent Bacterial Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818104.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3

Interaction between and polymorphonuclear leukocytes. (A) Phagocytes recruited to the mucosal surface can take up in the absence of opsonins via interactions between Opa proteins and the neutrophil CD66 receptor. An Opa-negative variant that has escaped this interaction is shown; variants expressing some Opa proteins within the Opa repertoire of a strain also do not adhere to neutrophils (reviewed in reference ). LOS sialylation catalyzed by gonococcal sialyltransferase (STase) inhibits Opa-mediated uptake by phagocytes ( ). (B) Stimulation of the phagocyte respiratory burst leads to the production of toxic oxygen radicals. Unlike many other bacteria, does not make superoxide dismutase, which could neutralize the respiratory burst at an early stage in toxic radical production. does produce high levels of catalase, which is capable of cleaving H2O2 to oxygen and water ( ). Increased production of gonococcal catalase occurs in response to sublethal concentrations of H2O2 ( ). (C) The gonococcus may effectively compete with the neutrophil for molecular O2 , which is limited on mucosal surfaces. Lactate produced by neutrophils or by commensal lactobacilli may give the gonococcus a competitive edge in that O2 is rapidly consumed during lactose utilization by ( ; reviewed in reference ). T h e resultant anaerobic environment increases activity and also the expression of LOS species carrying the lactose-N-tetraose molecule to which sialic acid is added, which together may help prevent phagocytosis ( ) (panel A). (D) Oxygen-independent killing mechanisms include the production of catliepsin G, a protease found in neutrophil lysozomes that inhibits gonococcal growth. The targets of catliepsin G are the bacterial transpeptidases used in peptidoglycan synthesis ( ) is resistant to neutrophil defensins ( ). Some gonococcal strains may utilize the lactoferrin released from neutrophil granules as a growth substrate (reviewed in reference ). An additional gonococcal defense that is not shown is the capacity of to directly impair phagocyte functions, including degranulation, actin polymerization, and phagocytosis, through insertion of its major porin, P.I, into the eukaryotic cell membrane ( ). This direct attack on neutrophils may further promote persistence during inflammation.

Citation: Jerse A. 2000. : Adaptation and Survival in the Urogenital Tract, p 201-227. In Nataro J, Blaser M, Cunningham-Rundles S (ed), Persistent Bacterial Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818104.ch11
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Anderson, J. E.,, P. F. Sparling,, and C. N. Cornelissen. 1994. Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization. J. Bacteriol. 176:31623170.
2. Apicella, M. A.,, K. M. Bennett,, C. A. Hermerath,, and D. E. Roberts. 1981. Monoclonal antibody analysis o f lipopolysaccharide from Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 34:751756.
3. Apicella, M. A.,, R. E. Mandrell,, M. Shero,, M. E. Wilson,, J. M. Griffiss,, G. F. Brooks,, C. Lammel,, J. F. Breen,, and P. A. Rice. 1990. Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J. Infect. Dis. 162:506512.
4. Apicella, M. A.,, M. Ketterer,, F. K. N. Lee,, D. Zhou,, P. A. Rice,, and M. S. Blake. 1996. The pathogenesis of gonococcal urethritis in men: confocal and immunoelectron microscopic analysis of urethral exudates from men infected with Neisseria gonorrhoeae. J. Infect. Dis. 173:636646.
5. Aral, S. O.,, and K. K. Holmes,. 1999. Social and behavioral determinants of the epidemiology of STDs: industrialized and developing countries,p.39–76. In K. K. Holmes,, P. A. Mardh,, P. F. Sparling,, S. M. Lemon,, W. E. Stamm,, P. Piot,, and J. N. Wasserheit (ed.), Sexually Transmitted Diseases, 3rd ed. McGraw-Hill Companies, Inc., New York, N.Y.
6. Archibald, F. S.,, and M. N. Duong. 1986. Superoxide dismutase and oxygen toxicity defenses in the genus Neisseria. Infect. Immun. 51:631641.
7. Arko, R. J. 1989. Animal models forpathogenic Neisseria species. Clin. Microbiol.Rev. 2:S56S59.
8. Arvidson, C. G.,, T. Powers,, P. Walter,, and M. So. 1999. Neisseria gonorrhoeae PilA is an FtsY homolog. J. Bacteriol. 181:731739.
9. Backman, M.,, H. Kallstrom,, and A. B. Jonsson. 1998. The phase-variable pilus-associated protein PilC is commonly expressed in clinical isolates of Neisseria gonorrhoeae, and shows sequence variability among strains. Microbiology 144:149156.
10. Banerjee, A.,, R. Wang,, S. N. Uljon,, P. A. Rice,, E. C. Gotschlich, a n d D. C. Stein. 1998. Identification of the gene (IgtG) encoding the lipooligosaccharide P-chain synthesizing glucosyl transferase from Neisseria gonorrhoeae. Proc. Natl. Acad. Sci. USA 95:1087210877.
11. Bartlett, J.G.,, and B. F. Polk. 1984. Bacterial flora of thevagina: quantitative study. Rev. Infect. Dis. 6(Suppl. 1):S67S72.
12. Belland, R. J.,, T. Chen,, J. Swanson,, and S. H. Fischer. 1992. Human neutrophil response to recombinant neisserial Opa proteins. Mol. Microbiol. 6:17291737.
13. Berish, S. A.,, S. Subbarao,, C. Y. Chen,, D. L. Trees,, and S. A. Morse. 1993. Identification and cloning of 2. fur homolog from Neisseria gonorrhoeae. Infect. Immun. 61:45994606.
14. Bessen, D.,, and E. C. Gotschlich. 1986. Interactions of gonococci with HeLa cells: attachment, detachment, rephcation, penetration, and the role of protein II. Infect. Immun. 54:154160.
15. Biro, F. M.,, S. L. Rosenthal,, and M. Kiniyalocts. 1995. Gonococcal and chlamydial genitourinary infections in symptomatic and asymptomatic adolescent women. Clin. Pediatr. 34:419423.
16. Bisno, A. L.,, I. Ofek,, E. H. Beachey,, R. W. Chandler,, and J. W. Curran. 1975. Human immunity to Neisseria gonorrhoeae: acquired serum op sonic antibodies. J. Lab. Clin. Med. 86:221229.
17. Biswas, G. D.,, and P. F. Sparling. 1995. Characterization of IbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect. Immun. 63:29582967.
18. Biswas, G. D.,, J. E. Anderson,, C. J. Chen,, C. N. Cornelissen,, and P. F. Sparling. 1999. Identification and functional characterization of the Neisseria gonorrhoeae IbpB gene product. Infect. Immun. 67:455459.
19. Bjerknes, R.,, H. K. Guttormsen,, C. O. Solberg,, and L. M. Wetzler. 1995. Neisserial porins inhibit human neutrophil actin polymerization, degranulation, opsonin receptor expression, and phagocytosis but prime the neutrophils to increase their oxidative burst. Infect. Immun. 63: 160167.
20. Black, C.G.,, J. A. M. Fyfe,, and J. K. Davies. 1995. A promoter associatedwith the neisserial repeat can be used to transcribe the uvrB gene from Neisseria gonorrhoeae. J. Bacteriol. 177:19521958.
21. Blake, M. S.,, K. K. Holmes,, and J. Swanson. 1979. Studies on gonococcus infection. XVII. IgAl-cleaving protease in vaginal washings from women with gonorrhea. J. Infect. Dis. 139:8992.
22. Bolan, G.,, A. A. Ehrhardt,, and J. N. Wasserheit,. 1999. Gender perspectivesand STDs, p. 117127. In K. K. Holmes,, P. A. Mardh,, P. F. Sparling,, S. M. Lemon,, W. E. Stamm,, P. Piot,, and J. N. Wasserheit (ed.), Sexually Transmitted Diseases, 3rd ed. McGraw-Hill Companies, Inc., New York, N.Y.
23. Bos, M. P.,, D. Hogan,, and R. J. Belland. 1997. Selection of Opa+ Neisseria gonorrhoeae by limited availability of normal human serum. Infect. Immun. 65:645650.
24. Boslego, J. W.,, E. C. Tramont,, R. C. Chung,, D. G. McChesney,, J. Ciak,, J. C. Sadoff,, M. V. Piziak,, J. D. Brown,, C. C. Brinton,, and S. W. Wood. 1991. Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine 9:154162.
25. Brandt, A.M. 1985. Damaged goods: progressive medicineand social hygiene, p.751. In No Magic Bullet. A Social History of Venereal Disease in the United States since 1880. Oxford University Press, New York, N.Y.
26. Braude, A.I.,, L. B. Corbeil,, S. Levine,, J. Ito,, and J. A. McCutchan,. 1978. Possible influence ofcyclic menstrual changes on resistance to the gonococcus, p.328337. In G. F. Brooks,, E. C. Gotschlich,, K. K. Holmes,, W. D. Sawyer,, and F. E. Young (ed.), Immunobiology of Neisseria gonorrhoeae. American Society for Microbiology, Washington, D.C.
27. Brinton, C.C.,, S. W. Wood,, A. Brown, tal. 1982. The development of aneisserial pilus vaccine for gonorrhea and meningococcal meningitis,p.140159. In L. Weinstein, and B. N. Fields (ed.), Seminars in Infectious Disease. Thieme-Stratton, New York, N.Y.
28. Britigan, B. E.,, D. Klapper,, T. Svendsen,, and M. S. Cohen. 1988. Phagocyte derived lactate stimulates oxygen consumption by Neisseria gonorrhoeae. J. Clin. Investig. 81:318324.
29. Britigan, B. E.,, M. S. Cohen,, and P. F. Sparling. 1985. Gonococcal infection: a model of molecular pathogenesis. N. Engl. J. Med. 312: 16831694.
30. Bro-Jorgensen, A.,, and T. Jensen. 1973. Gonococcal pharyngeal infections. Br. J. Vener. Dis. 49:491499.
31. Brooks, G. F.,, W. W. Darrow,, and J. A. Day. 1978. Repeated gonorrhea: an analysis of importance and risk factors. J. Infect. Dis. 137:161169.
32. Brooks, G.F.,, and C. J. Lammel. 1989. Humoral immune responseto gonococcal infections. Clin. Microbiol. Rev. 2(Suppl.):S5S10.
33. Brooks, G. F.,, L. Olinger,, C. J. Lammel,, K. S. Bhat,, C. A. Calvello,, M. L. Palmer,, J. S. Knapp,, and R. S. Stephens. 1991. Prevalence of gene sequences coding for hypervariable regions of Opa (protein II) in Neisseria gonorrhoeae. Mol. Microbiol. 5:30633072.
34. Buchanan, T. M.,, D. A. Eschenbach,, J. S. Knapp,, and K. K. Holmes. 1980. Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae o f the same principal outer membrane protein antigenic type. Am. J. Obstet. Gynecol. 138: 978980.
35. Burch, C. L.,, R. J. Danaher,, and D. C. Stein. 1997. Antigenic variation in Neisseria gonorrhoeae: production of multiple lipooligosaccharides. J. Bacteriol. 179:982986.
36. Butler, B. C.,, and J. W. Beakley. 1960. Bacterial flora in vaginitis. A study before and after treatment with pure cultures of Doderlein bacillus. Am. J. Obstet. Gynecol. 79:432440.
37.Centers for Disease Control and Prevention. 1996. Ten leading nationally notifiable infectious diseases—United States, 1995. Morbid. Mortal. Weekly Rep. 45:8834.
38. Chen, C. J.,, P. F. Sparling,, L. A. Lewis,, D. W. Dyer,, and C. Elkins. 1996. Identification and purification of a hemoglobin binding outer protein from Neisseria gonorrhoeae. Infect. Immun. 64:50085014.
39. Chen, C. J.,, C. Elkins,, and P. F. Sparling. 1998. Phase variation of hemoglobin utilization in Neisseria gonorrhoeae. Infect. Immun. 66:987993.
40. Chen, T.,, and E. C. Gotschlich. 1996. CGMla antigen of neutrophils, a receptor of gonococcal opacity proteins. Proc. Natl. Acad. Sci. USA 93: 1485114856.
41. Clark, V. L.,, L. A. Campbell,, D. A. Palermo,, T. M. Evans,, and K. W. Klimpel. 1987. Induction and repression of outer membrane proteins by anaerobic growth of Neisseria gonorrhoeae. Infect. Immun. 55:13591364.
42. Clark, V. L.,, J. S. Knapp,, S. Thompson,, and K. W. Klimpel. 1988. Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections. Microb. Pathog. 5:381390.
43. Cohen, M. S.,, B. E. Britigan,, M. French,, and K. Bean. 1987. Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am. J. Obstet. Gynecol. 157:11221125.
44. Cohen, M. S.,, J. G. Cannon,, A. E. Jerse,, L. M. Charniga,, S. F. Isbey,, and L. G. Whicker. 1994. Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology o f infection and vaccine development. J. Infect. Dis. 169:532537.
45. Cohen, M. S.,, and P. F. Sparling. 1992. Mucosal infection with Neisseria gonorrhoeae. J. Clin. Investig. 89:16991705.
46. Cohen, M. S.,, and W. C. Miller. 1998. Sexually transmitted diseases and human immunodeficiency virus infection: cause, effect or both? Int. J. Infect. Dis. 3:14.
47. Cohen, M.S.,, and J. G. Cannon. 1999. Human experimentationwith Neisseria gonorrhoeae: progress and goals. J. Infect.Dis. 179: S375S379.
48. Corbeil, L. B.,, A. Chatterjee,, L. Foresman,, and J. A. Westfall. 1985. Ultrastructure of cyclic changes in the murine uterus, cervix and vagina. Tissue Cell. 17:5368.
49. Cornelissen, C. N.,, G. D. Biswas,, J. Tsai,, D . K. Paruchuri,, S. A. Thompson,, and P. F. Sparling. 1992. Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB-dependent outer membrane receptors. J. Bacteriol. 174:57885797.
50. Cornelissen, C. N.,, M. Kelley,, M. M. Hobbs,, J. E. Anderson,, J. G. Cannon,, M. S. Cohen,, and P. F. Sparling. 1998. The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers. Mol. Microbiol. 27:611616.
51. Crawford, G.,, J. S. Knapp,, J. Hale,, and K. K. Holmes. 1977. Asymptomatic gonorrhea in men: caused by gonococci with unique nutritional requirements. Science 196:13521353.
52. Cucurull, E.,, and L. R. Espinoza. 1998. Gonococcal arthritis. Rheum Dis. Clin. N. Am. 24:305322.
53. Danaher, R. J.,, J. C. Levin,, D. Arking,, C. L. Burch,, R. Sandlin,, and D. C. Stein. 1995. Genetic basis of Neisseria gonorrhoeae lipooligosaccharide antigenic variation. J. Bacteriol. 177: 72757279.
54. Deheragoda, P. 1977. Diagnosis of rectal gonorrhoea by blind anorectal swabs compared with direct vision swabs taken via a proctoscope. Br. J. Vener. Dis. 53:311313.
55.Dehio, C.,, S. D. Gray-Owen,, and T. F. Meyer. 1998. The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol. 6:489495.
56. De la Paz, H.,, S.J. Cooke,, and J. E. Heckels. 1995. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement- mediated killing by monoclonal antibodies directed against different outer-membrane antigens. Microbiology 141:913920.
57.Division of STD Prevention. 1995. Sexually Transmitted Disease Surveillance, 1994. Centers for Disease Control and Prevention, Atlanta, Ga.
58. Dorig, R. E.,, A. Marcil,, and C. D. Richardson. 1994. CD46, a primate-specific receptor for measles virus. Trends Microbiol. 2:312318.
59. Dorwood, D. W.,, C. F. Garon,, and R. C. Judd. 1989. Export and intercellular transfer of DNA via membrane blebs of Neisseria gonorrhoeae. J. Bacteriol. 171:24992505.
60. Dyer, D. W.,, E. P. West,, and P. F. Sparling. 1987. Effects of serum carrier proteins on the growth of pathogenic neisseriae with hemebound iron. Infect. Immun. 55:21712175.
61. Eades-Perner, A. M.,, H. van der Putten,, A. Hirth,, J. Thompson,, M. Neumaier,, S. von Kleist,, and W. Zimmermann. 1994. Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern. Cancer Res. 54:41694176.
62. Elkins, C.,, and R. F. Rest. 1990. Monoclonal antibodies to outer membrane protein PII block interactions of Neisseria gonorrhoeae with human neutrophils. Infect. Immun. 58:10781084.
63. Elkins, C.,, N. H. Carbonetti,, V. A. Varela,, D. Stirewalt,, D. G. Klapper,, and P. F. Sparling. 1992. Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated. Mol. Microbiol. 6:26172628.
64. Eschenbach, D. A.,, J. P. Harnisch,, and K. K. Holmes. 1977. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am. J. Obstet. Gynecol. 128: 838850.
65. Falk, V.,, and G. Krook. 1967. Do results of culture for gonococci vary with sampling phase of menstrual cycle? Acta Derm. Venereol. 47: 190193.
66. Faruki, H.,, R. N. Kohmescher,, W. P. Mc- Kinney,, and P. F. Sparling. 1985. A community- based outbreak of infection with penicillinresistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). N. Engl. J. Med. 313:607611.
67. Fischer, S. H.,, and R. F. Rest. 1988. Gonococci possessing only certain P.II outer membrane proteins interact with human neutrophils. Infect. Immun. 56:15741579.
68. Flemming, T. J.,, D. E. Wallsmith,, and R. S. Rosenthal. 1986. Arthropathic properties of gonococcal peptidogjycan fragments: implications for the pathogenesis of disseminated gonococcal disease. Infect. Immun. 52:600608.
69. Fox, K. K.,, J. C. Thomas,, D. H. Weiner,, R. H. Davis,, P. F. Sparling,, and M. S. Cohen. 1999. Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. Am. J. Epidemiol. 149:353358.
70. Francioli, P.,, H. Shio,, R. B. Roberts,, and M. Muller. 1983. Phagocytosis and killing o f Neisseria gonorrhoeae by Trichomonas vaginalis. J. Infect. Dis. 147:8793.
71. Frangipane, J. V.,, and R. F. Rest. 1993. Anaerobic growth and cytidine 5'-monophospho-Nacetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae. Infect. Immun. 61:16571666.
72. Fyfe, J. A. M.,, C. S. Carrick,, and J. K. Davis. 1995. The pilE of Neisseria gonorrhoeae MS11 is transcribed from a cr7 0 promoter during growth in vitro. J. Bacteriol. 177:37813787.
73. Gill, M. J.,, D. P. McQuillen,, J. O. P. van Putten,, L. M. Wetzler,, J. Bramley,, H. Crooke,, N. J. Parsons,, J. A. Cole,, and H. Smith. 1996. Functional characterization of a sialyltransferase- deficient mutant of Neisseria gonorrhoeae. Infect. Immun. 64:33743378.
74. Glynn, A. A.,, and J. E. Ward. 1970. Nature and heterogeneity of the antigens of Neisseria gonorrhoeae involved in the serum bactericidal reaction. Infect. Immun. 2:162168.
75. Goldenberg, D. L.,, P. L. Chisholm,, and P. A. Rice. 1983. Experimental models ofbacterial .arthritis: a microbiologic and histopathologic characterization o f the arthritis after the intraarticular injections of Neisseria gonorrhoeae. Staphylococcus aureus, group A streptococci, and Escherichia coli. J. Rheumatol. 10:511.
76. Gorbach, S. L.,, K. B. Menda,, H. Thadepalli,, and L. Keith. 1973. Anaerobic microflora of the cervix in healthy women. Am. J. Obstet. Gynecol. 8:10531055.
77. Gorby, G. L.,, C. M. Clemens,, L. R. Barley,, and Z. A. McGee. 1991. Effect of human chorionic gonadotropin (hCG) on Neisseria gonorrhoeae invasion of and IgA secretion by human fallopian tube mucosa. Microb. Pathog. 10:373384.
78. Gorby, G. L.,, and G. B. Schaefer. 1992. Effect of attachment factors (pili plus Opa) on Neisseria gonorrhoeae invasion of human fallopian tube tissue in vitro: quantitation by computerized image analysis. Microb. Pathog. 13:93108.
79. Gotschlich, E.C.,, M. SeifF,, and M. S. Blake. 1987. The DNA sequence of the structural gene of gonococcal protein III and the flanking region containing a repetitive sequence. Homology of protein III with enterobacterial ompA proteins. J. Exp. Med. 165:471482.
80. Gotschlich, E. C. 1994. Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide. J. Exp. Med. 180: 21812190.
81. Griffiss, J.M.,, J. H. Schneider,, R. E. Mandrell,, R. Yamasaki,, G. A. Jarvis,, J. J. Kim,, B. W. Gibson,, R. Hamadeh,, and M. A. Apicella. 1988. Lipooligosaccharides: the principal glycolipids of the neisserial outer membrane. Rev. Infect. Dis. 10:S287S295.
82. Griffiss, J. M.,, G. A. Jarvis,, J. P. O'Brien,, M. M. Eads,, and H. Schneider. 1991. Lysis of Neisseria gonorrhoeae initiated by binding o f normal human IgM to a hexosamine-containing lipooligosaccharide epitope(s) is augmented by strainspecific, properdin-binding-dependent alternative complement pathway activation. J. Immunol. 147:298305.
83. Haas, R.,, S. Veit,, and T. F. Meyer. 1992. Silent pilin genes of Neisseria gonorrhoeae MS 11 and the occurrence of related hypervariant sequences among other gonococcal isolates. Mol. Microbiol. 6:197208.
84. Haines, K. A.,, L. Yeh,, M. S. Blake,, P. Cristello,, H. Korchak,, and G. Weissmann. 1988. Protein I, a translocatable i on channel from Neisseria gonorrhoeae, selectively inhibits exocytosis from human neutrophils without inhibiting 02 ~ generation. J. Biol. Chem. 263:945951.
85. Handsfield, H. H.,, T. O. Lipman,, J. P. Harnish,, E. Tronca,, and K. K. Holmes. 1974. Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. N. Engl. J. Med. 290:117123.
86. Harkness, A. H. 1948. The pathology of gonorrhoea. Br. J. Vener. Dis. 24:137147.
87. Harrison, W. O.,, R. R. Hooper,, P. J. Weisner,, A. F. Campbell,, W. W. Karney,, G. H. Reynolds,, O. G. Jones,, and K. K. Holmes . 1979. A trial of minocycHne given after exposure to prevent gonorrhea. N. Engl. J. Med. 300: 10741078.
88. Harvey, H. A.,, M. R. Ketterer,, A. Preston,, D. LubarofF,, R. Williams,, and M. A. Apicella. 1997. Ultrastructural analysis of primary human urethral epithelial cell cultures infected with Neisseria gonorrhoeae. Infect. Immun. 65: 24202427.
89. Hassett, D. J.,, L. Charniga,, and M. S. Cohen. 1990. recA and catalase in H202-mediated toxicity in Neisseria gonorrhoeae. J. Bacteriol. 172: 72937296.
90. Hauck, C.R.,, D. Lorenzen,, J. Salas,, and T. F. Meyer. 1997. An in vitro-differentiatedhuman cell line as a model system to the interaction of Neisseria gonorrhoeae withphagocytic cells. Infect. Immun. 65:18631869.
91. Hebeler, B. H.,, W. W. Wong,, S. A. Morse,, and F. E. Young. 1979. Cell envelope of Neisseria gonorrhoeae CS7: peptidoglycan-protein complex. Infect. Immun. 23:353359.
92. Hedges, S. R.,, M. S. Mayo,, L. Kallman,, J. Mestecky,, E. W. Hook,, and M. W. Russell. 1998. Evaluation of immunoglobulin A l (IgAl) protease and IgAl protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae. Infect. Immun. 66:58265832.
93. Hedges, S. R.,, D. A. Sibley,, M. S. Mayo,, E. W. Hook,, and M. W. Russell. 1998. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections. J. Infect. Dis. 178:742751.
94. Hipp, S. S.,, W. D. Lawton,, N. C. Chen,, and H. A. Gaafar. 1974. Inhibition of Neisseria gonorrhoeae by a factor produced by Candida albicans. Appl. Microbiol. 27:192196.
95. Hobbs, M. M.,, T. M. Alcorn,, R. H. Davis,, W. Fischer,, J. C. Thomas,, I. Martin,, C. Ison,, P. F. Sparling,, and M. S. Cohen. 1999. Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J. Infect. Dis. 179:371381.
96. Holmes, K. K.,, G. W. Counts,, and H. N. Beaty. 1971. Disseminated gonococcal infection. Ann. Intern. Med. 74:979993.
97. Hook, E. W.,, and K. K. Holmes. 1985. Gonococcal infections. Ann. Intern. Med. 102: 229243 .
98. Hook, E. W.,, D. A. Olsen,, and T. M. Buchanan. 1984. Analysis o f the antigen specificity of the human serum irrimunoglobulin G immune response to complicated gonococcal infection. Infect. Immun. 43:706709.
99. Hook, E.W.,, and H. H. Handsfield,. 1999. Gonococcal infectionsin the adult, p.451472. In K. K. Holmes,, P. A. Mardh,, P. F. Sparling,, S. M. Lemon,, W. E. Stamm,, P. Piot,, and J. N. Wasserheit (ed.), Sexually Transmitted Diseases, 3rd ed. McGraw-Hill Companies, Inc., New York, N.Y.
100. Householder, T. C.,, W. A. Belli,, S. Lissenden,, J. A. Cole,, and V. L. Clark. 1999. cisand trans-acting elements involved in regulation of aniA, the gene encoding the major anaerobically induced outer membrane protein in Neisseria gonorrhoeae. J. Bacteriol. 181:541551.
101. liver, D.,, H. Kallstrom,, S. Normark,, and A. B. Jonsson. 1998. Transcellular passage of Neisseria gonorrhoeae involves pilus phase variation. Infect. Immun. 66:469473.
102. James, J.F.,, and J. Swanson,. 1978. Color/opacity colonialvariants of Neisseria gonorrhoeae and their relationship to the menstrualcycle, p.338343. In G. F. Brooks,, E. C. Gotschlich,, K. K. Holmes,, W. D. Sawyer,, and F. E. Young (ed.), Immunobiology of Neisseria gonorrhoeae. American Society for Microbiology, Washington, D.C.
103. James, J. F.,, and J. Swanson. 1978. Studies on gonococcus infection. XIII. Occurrence of color/opacity colonial variants in clinical cultures. Infect. Immun. 19:332340.
104. Jerse, A. E.,, J. S. Cohen,, P. M. Drown,, L. G. Whicker,, S. F. Isbey,, H. S. Seifert,, and J. G. Cannon. 1994. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179: 911920.
105. Jerse, A. E. 1999. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67: 56995708.
106. Johnson, A. P.,, M. Tufirey,, and D. Taylor- Robinson. 1989. Resistance of mice to genital infection with Neisseria gonorrhoeae. J. Med. Microbiol. 30:3336.
107. Johnson, D. W.,, K. K. Holmes,, P. A. Kvale,, C. W. Halverson,, and W. P. Hirsch. 1969. An evaluation of gonorrhea case finding in the chronically infected female. Am. J. Epidemiol. 90: 438448.
108. Johnson, S.R.,, B. M. Steiner,, D. D. Cruce,, G. H. Perkins,, and R. J. Arko. 1993. Characterization o f a catalase-deficient strain of Neisseria gonorrhoeae: evidence for the significance of catalase in the biology of N. gonorrhoeae. Infect. Immun. 61:12321238.
109. Johnson, S. R.,, B. M. Steiner,, and G. H. Perkins. 1996. Cloning and characterization of the catalase gene of Neisseria gonorrhoeae: use of the gonococcus as a host organism for recombinant DNA. Infect. Immun. 64:26272634.
110. Jonsson, A. B.,, G. Nyberg,, and S. Normark. 1991. Phase variation of gonococcal pilli by frameshift mutation in pilC, a novel gene for pilus assembly. EMBOJ. 10:477488.
111. Kallstrom, H.,, M. K. Liszewski,, J. P. Atkinson,, and A. B. Jonsson. 1997. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol. Microbiol. 25:639647.
112. Kampmeier, R. H. 1978. Identification of the gonococcus by Albert Neisser. Sex. Transm. Dis. 5:7172.
113. Kellogg, D. S., Jr.,, I. R. Cohen,, L. C. Norins,, A. L. Schroeter,, and G. Reising. 1968. Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro. J. Bacteriol. 96:596605.
114. Kellogg, D. S.,, W. L. Peacock,, W. E. Deacon,, L. Brown,, and C. I. Pirkle. 1963. Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. J. Bacteriol. 85:12741279.
115. Kerle, K. K.,, J. R. Mascola,, and T. A. Miller. 1992. Disseminated gonococcal infection. Am. Fam. Physician 45:209214.
116. Kilian, M.,, J. Mestecky,, and M. W. Russell. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52:296303.
117. Kita, E.,, H. Matsuura,, and S. Kashiba. 1981. A mouse model for the study of gonococcal genital infection. J. Infect. Dis. 143:6770.
118. Kita, E.,, S. Takahashi,, K. Yasui,, and S. Kashiba. 1985. Effect of estrogen (170-estradiol) on the susceptibility of mice to disseminated gonococcal infection. Infect. Immun. 49:238243.
119. Klaus, B. D.,, J. E. Chandler,, and P. E. Dans. 1978. Gonorrhea detection in posthysterectomy patients. JAMA 240:13601361.
120. Klimpel, K. W.,, S. A. Lesley,, and V. L. Clark. 1989. Identification of subunits of gonococcal RNA polymerase by immunoblot analysis: evidence for multiple sigma factors. J. Bacteriol. 171:37133718.
121. Knapp, J. S.,, and V. L. Clark. 1984. Anaerobic growth of Neisseria gonorrhoeae coupled to nitrite reduction. Infect. Immun. 46:176181.
122. Koch, M. L. 1947. A study of cervical cultures taken in cases of acute gonorrhea with special reference to the phases of the menstrual cycle. Am. J Obstet. Gynecol. 54:861866.
123. Koch, M. L. 1950. The bactericidal action of beta progesterone. Am. J. Obstet. Gynecol. 59:168171.
124. Kupsch, E. M.,, B. Knepper,, T. Kuroki,, I. Heuer,, and T. F. Meyer. 1993. Variable opacity (Opa) outer membrane proteins account for the cell tropisms displayed by Neisseria gonorrhoeae for human leukocytes and epithelial cells. EMBO J. 12:641650.
125. Kutteh, W. H.,, S. J. Prince,, K. R. Hammond,, C. C. Kutteh,, and J. Mestecky. 1996. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Exp. Immunol. 104:538542.
126. Lambden, P.R.,, and J. E. Heckels. 1979. Outer membrane protein composition and colonial morphology of Neisseria gonorrhoeae strain P9. FEMS Microbiol. Lett. 5:263265.
127. Lambden, P. R.,, J. E. Heckels,, and P. J. Watt. 1982. Effect of anti-pilus antibodies on survival of gonococci within guinea pig subcutaneous chambers. Infect. Immun. 38:2730.
128. Lanigan-O'Keefe, F. M. 1974. Prepubertal gonorrhoea. Br. J. Vener. Dis. 50:381.
129. Laskos, L.,, J. P. Dillard,, H. S. Seifert,, J. A. M. Fyfe,, and J. K. Davies. 1998. The pathogenic neisseriae contain an inactive rpoN gene and do not utilize the pilE a 54 promoter. Gene 208:95102.
130. LebedefF, D. A.,, and E. B. Hochman. 1980. Rectal gonorrhea in men: diagnosis and treatment. Ann. Intern. Med. 92:463466.
131. Lee, B. C.,, and A. B. Schryvers. 1988. Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae. Mol. Microbiol. 2: 827829.
132. Lin, L.,, P. Ayala,, J. Larson,, M. Mulks,, M. Fukuda,, S. R. Carlsson,, C. Enns,, and M. So. 1997. The Neisseria type 2 IgAl protease cleaves LAMP1 and promotes survival of bacteria within epithelial cells. Mol. Microbiol. 24: 10831084.
133. Lowe, T. L.,, and S.J. Kraus. 1976. Quantitation of Neisseria gonorrhoeae from women with gonorrhea. J. Infect. Dis. 133:621626.
134. Lucas, J. B.,, E. V. P Rice,, J. D. Thayer,, and A. Schroeter. 1967. Diagnosis and treatment of gonorrhea in the female. N. Engl. J. Med. 276: 14541459.
135. Magnusson, K. E.,, E. Kihlstrom,, L. Norlander,, A. Norqvist,, J. Davies,, and S. Normark. 1979. Effect of colony type and pH on surface charge and hydrophobicity of Neisseria gonorrhoeae. Infect. Immun. 26:397401.
136. Mandrell, R.,, H. Schneider,, M. Apicella,, W. Zollinger,, P. A. Rice,, and J. M. Griffiss. 1986. Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect. Immun. 54:6369.
137. Mandrell, R. E.,, H. Smith,, G. A. Jarvis,, J. M. Griffiss,, and J. A. Cole. 1993. Detection and some properties of the sialyltransferase implicated in the sialylation of lipopolysaccharide of Neisseria gonorrheae. Microb. Pathog. 14:307313.
138. Mandrell, R. E.,, and M. A. Apicella. 1993. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187:382402.
139. Mardh, P.-A.,, and L. Westrom. 1976. Adherence of bacteria to vaginal epithelial cells. Infect. Immun. 13:661666.
140. Masson, P. L.,, J. F. Heremans,, and J. Ferin. 1968. Presence of an iron-binding protein (lactoferrin) in the genital tract o f the human female. I. Its immunohistochemical localization in the endometrium. Fertil. Steril. 19:679689.
141. McBride, H. M.,, P. R. Lamden,, J. E. Heckels,, and P. J. Watt. 1981. The role of outer membrane proteins in the survival of Neisseria gonorrhoeae P9 within guinea-pig subcutaneous chambers. J. Gen. Microbiol. 126:6367.
142. McCormack, W. M.,, R. J. Stumacher,, K. Johnson,, A. Donner,, and R. Rychwalski. 1977. Clinical spectrum of gonococcal infection in women. Lancet 2:11821185.
143. McCormack, W. M.,, G. H. Reynolds, and the Cooperative Study Group. 1982. Effect of menstrual cycle and method of contraception on recovery of Neisseria gonorrhoeae. JAMA 247: 12921294.
144. McCutchan, J. A.,, A. Wunderlich,, and A. I. Braude. 1977. Role of urinary solutes in natural immunity to gonorrhea. Infect. Immun. 15: 149155.
145. McChesney, D.,, E. C. Tramont,, J. W. Boslego,, J. Ciak,, J. SadofF,, and C. C. Brinton. 1982. Genital antibody response to a parenteral gonococcal pilus vaccine. Infect. Immun. 36: 10061012.
146. McGee, A. A.,, R. L. Jensen,, C. M. Clemens,, D. Taylor-Robinson,, A. P. Johnson,, and C. R. Gregg. 1999. Gonococcal infection of human fallopian tube mucosa in organ culture: relationship of mucosal tissue TNF-alpha concentration to sloughing of ciliated cells. Sex. Transm. Dis. 26:160165.
147. Merz, A. J.,, D. B. Rifenbery,, C. G. Arvidson,, and M. So. 1996. Traversal of polarized epithelium by pathogenic Neisseriae: facilitation by type IV pili and maintenance of epithelial barrier function. Mol. Med. 2:745754.
148. Meyer, T.F.,, and J. P. M. vanPutten. 1989. Genetic mechanisms and biologicalimplications of phase variation in pathogenic Neisseriae. Clin. Microbiol.Rev. 2:S139S145.
149. Mickelsen, P. A.,, and P. F. Sparling. 1981. Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect. Immun. 33:555564.
150. Mickelsen, P. A.,, E. Blackman,, and P. F. Sparling. 1982. Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin. Infect. Immun. 35:915920.
151. Mims, C.A., 1997. The encounter of the microbe withthe phagocytic cell, p. 60105. In N. Dimmock,, A. Nash,, J. Stephen,, and C. A. Mims (ed.), The Pathogenesis of Infectious Disease, 4th ed. Academic Press, Inc., San Diego, Calif.
152. Morse, S. A.,, and T. J. Fitzgerald. 1974. Effect of progesterone on Neisseria gonorrhoeae. Infect. Immun. 10:13701377.
153. Mosleh, I. M.,, H. J. Boxberger,, M. J. Sessler,, and T. F. Meyer. 1997. Experimental infection o f native human urethral tissue with Neisseria gonorrhoeae: adhesion, invasion, intracellular fate, exocytosis, and passage through a stratified epithelium. Infect. Immun. 65:33913398.
154. Mrkic, B., J. Pavlovic,, T. Rulicke,, P. Volpe,, C. J. Buchholz,, D. Hourcade,, J. P. Atkinson,, A. Aguzzi,, and R. Cattaneo. 1998. Measles virus spread and pathogenesis in genetically modified mice. J. Virol. 72:74207427.
155. Naids, F. L.,, B. Belisle,, N. Lee,, and R. F. Rest. 1991. Interactions of Neisseria gonorrhoeae with human neutrophils: studies with purified PII (Opa) outer membrane proteins and synthetic opa peptides. Infect. Immun. 59: 46284635.
156. Naids, F. L.,, and R. F. Rest. 1991. Stimulation of human neutrophil oxidative metabolism by nonopsonized Neisseria gonorrhoeae. Infect. Immun. 59:43834390.
157. Naumann, M.,, S. Webler,, C. Bartsch,, B. Wieland,, and T. F. Meyer. 1997. Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor KB and activator protein 1 and the induction of inflammatory cytokines. J. Exp. Med. 186: 247258.
158. Novotny, P.,, E. S. Broughton,, K. Cownley,, M. Hughes,, and W. H. Turner. 1978. Strain related infectivity of Neisseria gonorrhoeae for the guinea-pig subcutaneous chamber and the variability of the immune resistance in different breeds of guinea pig. Br. J. Vener. Dis. 54:8896.
159. Nowicki, S.,, M. G. Martens,, and B. J. Nowicki. 1995. Gonococcal infection in a nonhuman host is determined by human complement Clq. Infect. Immun. 63:47904794.
160. O'Brien, J. P.,, D. L. Goldenberg,, and P. A. Rice. 1983. Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine 62:395406.
161. Pariser, H. 1972. Asymptomatic gonorrhea. Med. Clin. N. Am. 56:11271132.
162. Patton, D.L.,, and R. G. Rank,. 1992. Animal models for the studyof pelvic inflammatory disease, p. 85111. In T. Quinn (ed.), Advances in Host Defense Mechanisms. Book News Inc., Portland, Oreg.
163. Petricoin, E. F.,, R. J. Danaher,, and D. C. Stein. 1991. Analysis of the hi region involved in lipooligosaccharide biosynthesis in Neisseria gonorrhoeae. J. Bacteriol. 173:78967902.
164. Pettit, R. K.,, E. S. Martin,, S. M. Wagner,, and V. J. Bertolino. 1995. Phenotypic modulation of gonococcal lipooligosaccharide in acidic and alkaline culture. Infect. Immun. 63: 27732775.
165. Pettit, R. K.,, M. J. Filiatrault,, and E. S. Martin. 1996. Alteration of gonococcal protein expression in acidic culture. Infect. Immun. 64: 10391042.
166. Pettit, R. K.,, S. C. McAllister,, and T. A. Hamer. 1999. Response of gonococcal clinical isolates to acidic conditions. J. Med. Microbiol. 48:149156.
167. Phillips, R. S.,, P. A. Hanff,, A. Wertheimer,, M. D. Aronson. 1988. Gonorrhea in women seen for routine gynecologic care: criteria for testing. Am. J. Med. 85:177182.
168. Piatt, R.,, P. A. Rice,, and W. M. McCormack. 1983. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recendy exposed to gonorrhea. JAMA 250:32053209.
169. Plummer, F. A.,, H. Chubb,, J. N. N. Simonsen,, M. Bosire,, L. Slaney,, N. J. Nagelkenke,, I. MacClean,, and J. O. Ndinga- Ayola. 1994. Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis. J. Clin. Investig. 93:17481755.
170. Plummer, F.A. ,, J. N. Simonsen,, H. Chubb,, L. Sianey,, J. Kimata,, M. Bosire,, J. O. Ndinya - Achola,, and E. N. Ngugi. 1989. Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J. Clin. Investig. 83:14721476.
171. Plummer, F. A.,, H. Chubb J,. N. Simonsen,, M. Bosire,, L. Slaney,, I. Maclean, J. O. Ndinya - Achola,, P. Waiyaki,, and R. C. Brunham. 1993. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection. J. Clin. Investig. 91:339343.
172. Porat, N.,, M. A. Apicella,, and M. S. Blake. 1995. Neisseria gonorrhoeae utilizes and enhances the biosynthesis of the asialoglycoprotein receptor expressed on the surface of the hepatic HepG2 cell line. Infect. Immun. 63:14981506.
173. Punsalang, A. P.,, and W. D. Sawyer. 1973. Role of pili in the virulence of Neisseria gonorrhoeae. Infect. Immun. 8:255263.
174. Qu, X. D.,, S. S. Harwig,, A. M. Oren,, W. M. Shafer,, and R. I. Lehrer. 1996. Susceptibility of Neisseria gonorrhoeae to protegrins. Infect. Immun. 64:12401245.
175. Quinn, T. C.,, W. E. Stamm,, S. E. Goodell,, E. Mkrtichian,, J. Benedetti,, L. Corey,, M. D. Schuffler,, and K. K. Holmes. 1983. The polymicrobial origin of intestinal infections in homosexual men. N. Engl. J. Med. 309:576582.
176. Ramsey, K. H.,, H. Schneider,, A. S. Cross,, J. W. Boslego,, D. L. Hoover,, T. L. Staley,, R. A. Kuschner,, and C. D. Deal. 1995. Inflammatory cytokines produced in response to experimental human gonorrhea. J. Infect. Dis. 172:186191.
177. Ravn, V.,, C. Stubbe,, U. Mandel,, and E. Da-belsteen. 1992. The distribution o f type-2 chain histo-blood group antigens in normal cycling human endometrium. Cell Tissue Res. 270:425433.
178. Redondo-Lopez, V.,, R. L. Cook,, and J. D . Sobel. 1990. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev. Infect. Dis. 12:856872.
179. Rees, E.,, and E. H. Annels. 1969. Gonococcal salpingitis. Br. J. Vener. Dis. 45:205215.
180. Reid, G.,, A. W. Bruce,, and M. Taylor. 1992. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin. Ther. 14:1116.
181. Rest, R. F.,, S. H. Fischer,, Z. Z. Ingham,, and J. F. Jones. 1982. Interactions of Neisseria gonorrhoeae with human neutrophils: effects of serum and gonococcal opacity on phagocyte killing and chemiluminescence. Infect. Immun. 36:737744.
182. Rest, R. F.,, and J. V. Frangipane. 1992. Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacityassociated outer membrane protein-mediated) interactions with human neutrophils. Infect. Immun. 60:989997.
183. Rice, P. A.,, and D. L. Goldenberg. 1981. Clinical manifestations of disseminated infection caused by Neisseria gonorrhoeae are linked to differences in bactericidal reactivity of infecting strains. Ann. Intern. Med. 95:175178.
184. Rice, P. A.,, H. E. Vayo,, M. R. Tarn,, and M. S. Blake. 1986. Immunoglobulin G antibodies directed against protein III block killing of serum-resistant Neisseria gonorrhoeae by immune serum. J. Exp. Med. 164:17351748.
185. Rice, P.A. 1989. Molecular basis for serumresistance in Neisseria gonorrhoeae. Clin. Microbiol.Rev. 2:S112S117.
186. Richardson, W. P.,, and J. C. SadofF. 1988. Induced engulfment of Neisseria gonorrhoeae by tissue culture cells. Infect. Immun. 56:25122514.
187. Rompalo, A. M.,, E. W. Hook,, P. L. Roberts,, M. D. Ramsey,, H. Handsfield,, and K. K. Holmes. 1957. The acute arthritis-dermatitis syndrome. The changing importance of Neisseria gonorrhoeae and Neisseria meningitidis. Arch. Intern. Med. 147:281283.
188. Ross, S. C, and P. Densen. 1985. Opsonophagocytosis of Neisseria gonorrhoeae: interaction of local and disseminated isolates with complement and neutrophils. J. Infect. Dis. 151:3341.
189. Rothbard, J. B.,, R. Fernandez,, L. Wang,, N. H. Teng,, and G. K. Schoolnik. 1985. Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion. Proc. Natl. Acad. Sci. USA 82:915919.
190. Saigh, J. H.,, C. C. Sanders,, and W. E. Sanders. 1978. Inhibition of Neisseria gonorrhoeae by aerobic and facultatively anaerobic components of the endocervical flora: evidence for a protective effect against infection. Infect. Immun. 19: 704710.
191. Salit, I. E. 1982. The differential susceptibility of gonococcal opacity variants to sex hormones. Can. J. Biochem. 60:301306.
192. Sarafian, S. K.,, M. R. Tarn,, and S. A. Morse. 1983. Gonococcal protein I-specific IgG in normal human serum. J. Infect. Dis. 148: 10251032.
193. Sayeed, Z. A.,, U. Bhaduri,, E. Howell,, and H. L. Meyers. 1972. Gonococcal meningitis. JAMA 219:17301731.
194. Scheuerpflug, I.,, T. Rudel,, R. Ryll,, J. Pandit,, and T. F. Meyer. 1999. Roles of PilC and PilE proteins in pilus-mediated adherence of Neisseria gonorrhoeae and Neisseria meningitidis to human erythrocytes and endothelial and epithelial cells. Infect. Immun. 67:834843.
195. Schiller, N. L.,, G. L. Friedman,, and R. B. Roberts. 1979. The role of natural IgG and complement in the phagocytosis of type 4 Neisseria gonorrhoeae by human polymorphonuclear leucocytes. J. Infect. Dis. 140:698707.
196. Schneider, H.,, J. M. Griffiss,, G. D. Williams,, and G. B. Pier. 1982. Immunological basis of serum resistance of Neisseria gonorrhoeae. J Gen. Microbiol. 128:1322.
197. Schneider, H.,, T. L. Hale,, W. D. Zollinger,, R. C. Seid,, C. A. Hammack,, and J. M. Griffiss. 1984. Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 45:544549.
198. Schneider, H.,, J. M. Griffiss,, R. E. Mandrell,, and G. A. Jarvis. 1985. Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae. Infect. Immun. 50:672677.
199. Schneider, H.,, J. M. Griffiss,, J. W. Boslego,, P. J. Hitchcock,, K. M. Zahos,, and M. A. Apicella. 1991. Expression of paraglobosidelike lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J. Exp. Med. 174:16011605.
200. Schneider, H.,, K. A. Schmidt,, D. R. Skillman,, L. van de Verg,, R. L. Warren,, H. J. Wylie,, J. C. SadofF,, C. D. Deal,, and A. S. Cross. 1996. Sialylation lessens the infectivity of Neisseria gonorrhoeae MSllmkC. J. Infect. Dis. 173:14221427.
201. Seifert, H. S. 1996. Questions about gonococcal pilus phase and antigenic variation. Mol. Microbiol. 21:433440.
202. Seifert, H. S.,, C. J. Wright,, A. E. Jerse,, M. S. Cohen,, and J. G. Cannon. 1994. Multiple gonococcal pilin antigenic variants are produced during experimental human infections. J. Clin. Investig. 93:27442749.
203. Shafer, W. M.,, and R. F. Rest. 1989. Interactions of gonococci with phagocytic cells. Annu. Rev. Microbiol. 43:121145.
204. Shafer, W. M.,, V. C. Onunka,, M. Jannoun,, and L. W. Hutwaite. 1990. Molecular mechanism for the anti-gonococcal action of lysosomal cathepsin G. Mol. Microbiol. 4:12691277.
205. Shapiro, R.A.,, C. J. Schubert,, and P. A. Myers. 1993. Vaginal discharge as anindicator of gonorrhea and Chlamydia infection in girls under 12 years old. Pediatr. Emerg. Care 9: 341345.
206. Shaw, J. H.,, and S. Falkow. 1988. Model for invasion of human tissue culture cells by Neisseria gonorrhoeae. Infect. Immun. 56:16251632.
207. Sherrard, J.,, and D. Barlow. 1996. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin. Med. 72:422426.
208. Shtibel, R. 1976. Inhibition of growth of Neisseria gonorrhoeae by bacterial interference. Can. J. Microbiol. 22:14301436.
209. Simon, D.,, and R. F. Rest. 1992. Escherichia coli expressing a Neisseria gonorrhoeae opacity-associated outer membrane protein invade human cervical and endometrial epithelial cell lines. Proc. Natl. Acad. Sci. USA 89:55125516.
210. Singer, A. 1975. The uterine cervix from adolescence to the menopause. Br. J. Obstet. Gynaecol. 82:8199.
211. Skerman, J. K.,, and K. K. Holmes. 1975. Disseminated gonococcal infections caused by Neisseria gonorrhoeae. J. Infect. Dis. 132:204208.
212. Smith, H.,, N. J. Parson,, and J. A. Cole. 1995. Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity. Microb. Pathog. 19:365377.
213. Sparling, P.F.,, J. Tsai,, and C. N. Cornelissen. 1990. Gonococci aresurvivors. Scand. J. Infect. Dis. 69:S125S136.
214. Spence, J. M.,, C. Chen,, and V. L. Clark. 1997. A proposed role for the lutropin receptor in contact-inducible gonococcal invasion of the Hecl B cells. Infect. Immun. 65:37363742.
215. Spink, W. W.,, and C. S. Keefer. 1937. Latent gonorrhea as a cause of acute polyarticular arthritis. JAMA 109:325328.
216. Stephens, D.S. 1989. Gonococcal and meningococcalpathogenesis as defined by human cell, cell culture, and organ culture assays. Clin. Microbiol. Rev. 2:S104S111.
217. Streeter, P. R.,, and L. B. Corbeil. 1981. Gonococcal infection in endotoxin-resistant and endotoxin-susceptible mice. Infect. Immun. 32: 105110.
218. Sugasawara, R. J.,, J. G. Cannon,, W. J. Black,, I. Nachamkin,, R. L. Sweet,, and G. F. Brooks. 1983. Inhibition of Neisseria gonorrhoeae attachment to HeLa cells with monoclonal antibody directed against a protein II. Infect. Immun. 42:980985.
219. Swanson, J. 1982. Colony opacity and protein II compositions of gonococci. Infect. Immun. 37:359368.
220. Swanson, J. 1972. Studies on gonococcus infection. Pili: their role in attachment of gonococci to tissue culture cells. J. Exp. Med. 137:571589.
221. Swanson, J.,, O. Barrera,, J. Sola,, and J. Boslego. 1988. Expression of outer membrane protein II by gonococci in experimental gonorrhea. J. Exp. Med. 168:21212129.
222. Swanson, J.,, K. Robbins,, O. Barrera,, D. Corwin,, J. Boslego,, J. Ciak,, M. Blake,, and J. M. Koomey. 1987. Gonococcal pilin variants in experimental gonorrhea. J. Exp. Med. 165: 13441357.
223. Sweet, R.L.,, M. Blankfort-Doyle,, M. O. Robbie,, and J. Schacter. 1986. The occurrence ofchlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 255:20622064.
224. Taha, M. K.,, B. Dupuy,, W. Saurin,, M. So,, and C. Marchal. 1991. Control of pilus expression in Neisseria gonorrhoeae: an original system in the family of two-component regulators. Mol. Microbiol. 5:137148.
225. Taylor-Robinson, D.,, P. M. Furr,, and C. M. Hetherington. 1990. Neisseria gonorrhoeae colonises the genital tract of oestradiol-treated germ-free female mice. Microb. Pathog. 9:369374.
226. Thomas, C. E.,, and P. F. Sparling. 1996. Isolation and analysis of a fur mutant Neisseria gonorrhoeae. J. Bacteriol. 178:42244232.
227. Tikly, M.,, M. Diese,, N. Zannettou,, and R. Essop. 1997. Gonococcal endocarditis in a patient with systemic lupus erythematosus. Br. J. Rheumatol. 36:270272.
228. Tonjum, T.,, and M. Koomey. 1997. The pilus colonization factor of pathogenic neisserial species: organelle biogenesis and structure/ function relationship—a review. Gene 192:155163.
229. Tramont, E. C. 1976. Specificity of inhibition of epithelial cell adhesion of Neisseria gonorrhoeae. Infect. Immun. 14:593595.
230. Turner, C.D.,, and J. T. Bagnara. 1976. Endocrinology of theovary, p.450495. In General Endocrinology. The W. B. Saunders Company, Philadelphia, Pa.
231. Upchurch, D. M.,, W. E. Brady,, C. A. Reichart,, and E. W. Hook HI. 1990. Behavioral contributions to acquisition of gonorrhea in patients attending an inner city sexually transmitted disease clinic. J. Infect. Dis. 161:938941.
232.U. S. Department ofHealth and Human Services. 1991. Pelvic inflammatory disease.Research directions in the 1990s. Sex. Transm. Dis. 18:4664.V
233. vanPutten, J. P. M. 1993. Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae. EMBO J. 12:40434051.
234. Virji, M.,, S. M. Watt,, S. Barker,, K. Makepeace,, and R. Doyonnas. 1996. The N-do-main of thehuman CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol. 22: 929939.
235. Virji, M.,, K. Makepeace,, D. J. P. Ferguson,, and S. M. Watt. 1996. Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol. Microbiol. 22:941950.
236. Wallin, J.,, and M. S. Siegel. 1979. Pharyngeal Neisseria gonorrhoeae: coloniser or pathogen? Br. Med. J 1:14621463.
237. Wang, J.,, S. D. Gray-Owen,, A. Knorre,, T. F. Meyer,, and C. Dehio. 1998. Opa binding to cellular CD66 receptors mediates the transcellular traversal of Neisseria gonorrhoeae across polarized T84 epithelial cell monolayers. Mol. Microbiol. 30:657671.
238. Ward, M. E.,, P. J. Watt,, and A. A. Glynn. 1970. Gonococci in urethral exudates possess a virulence factor lost on subculture. Nature 227:382384.
239. Ward, M. E.,, and P. J. Watt. 1972. Adherence of Neisseria gonorrhoeae to urethral mucosal cells: electron-microscopic study o f human gonorrhea. J. Infect. Dis. 126:601605.
240. Ward, M.E.,, J. N. Robertson,, P. M. Englefield,, and P. J. Watt,. 1975. Gonococcal infection:invasion of the mucosal surfaces of the genital tract, p. 188189. In D. Schlessinger (ed.), Microbiology. American Society for Microbiology, Washington, D.C.
241. Washington, E.,, and P. Katz. 1991. Cost of and payment source for pelvic inflammatory disease. JAMA 13:25652569.
242. Weinberg, E. D. 1978. Iron and infection. Microbiol. Rev. 42:4566.
243. Westrom, L.,, and D. Eschenbach,. 1999. Pelvic inflammatorydisease, p.783809. In K. K. Holmes,, P. A. Mardh,, P. F. Sparling,, S. M. Lemon,, W. E. Stamm,, P. Piot,, and J. N. Wasserheit (ed.), Sexually Transmitted Diseases, McGraw-Hill Companies, Inc., New York, N.Y.
244. Wetzler, L. M.,, K. Barry,, M. S. Blake,, and E. C. Gotschlich. 1992. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect. Immun. 60:3943.
245. Wiesner, P. J.,, E. Tronca,, P. Bonin,, A. Pedersen,, and K. K. Holmes. 1973. Clinical spectrum of pharyngeal gonococcal infection. N. Engl. J. Med. 288:181185.
246. Wilks, M.,, and S. Tabaqchali. 1987. Quantitative bacteriology of the vaginal flora during the menstrual cycle. J. Med. Microbiol. 24:241245.